Related Experiment Videos
Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features
G M Caputo1, G L Archer, S B Calderwood
1Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts 02215.
The American Journal of Medicine
|October 1, 1987
Summary
Coagulase-negative staphylococci (CoNS) can cause serious native valve endocarditis, often with severe complications. Prompt diagnosis and appropriate antibiotic selection are crucial for successful treatment outcomes.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Native valve endocarditis (NVE) is a serious infection.
- Coagulase-negative staphylococci (CoNS) are increasingly recognized as pathogens in NVE.
- Many patients with CoNS NVE have underlying valvular or congenital heart disease.
Purpose of the Study:
- To investigate the clinical presentation, complications, and outcomes of NVE caused by CoNS.
- To evaluate the antibiotic susceptibility patterns of CoNS isolates from patients with endocarditis.
- To highlight the importance of identifying CoNS in blood cultures as a potential indicator of endocarditis.
Main Methods:
- Retrospective study of 21 patients with NVE due to CoNS.
- Clinical data collection on patient demographics, comorbidities, presentation, complications, and treatment.
- Microbiologic analysis of CoNS isolates, including antibiotic susceptibility testing.
Main Results:
- Frequent complications observed, including arterial emboli (5/21), conduction abnormalities (9/21), and congestive heart failure (8/21).
- High cure rates achieved with both medical (10/12) and surgical (7/9) management.
- All isolates were susceptible to vancomycin; antibiotic resistance (methicillin, gentamicin, rifampin) was noted, often linked to nosocomial infections.
Conclusions:
- CoNS in blood cultures should not be dismissed as contamination and may signify life-threatening endocarditis.
- Careful antibiotic selection, including testing for cryptic beta-lactam resistance, and management of intracardiac complications are vital for successful treatment.
- Valve replacement may be frequently necessary in managing CoNS endocarditis.